Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tandem Auto-Allo Transplant for Lymphoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
Yi-Bin A. Chen, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01181271
First received: August 12, 2010
Last updated: July 28, 2015
Last verified: July 2015